Improved method for preparing ginkgo extracts having a low content of 4'-o-methyl pyridoxine and/or biflavones
A technology of methyl pyridoxine and extract, which is used in food preparation, medical raw materials derived from Ginkgo biloba, drug combination and other directions
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
example 1
[0066] Example 1: Ginkgo biloba extract with reduced content of 4'-O-methylpyridoxine
[0067] 1249 g of the extract solution obtained according to the above preparation method were adjusted with water until the ethanol content was about 40% (w / w) and applied to 50 ml (corresponding to 0.28 ml per gram of dry extract) of Amberlite IR-120 (strongly acidic ion exchanger ) (column: about 2×16.5 cm; flow rate: about 8 ml / min) (step I)), followed by washing with 200 ml of 50% ethanol (w / w). The resulting solution was concentrated on a rotary evaporator and dried in vacuo at 50° C. (step m)): 179.4 g.
[0068] As can be seen from the table below, a 4'-O-methylpyridoxine content of 0.4 ppm was achieved without substantially changing the content of components relevant to efficacy.
example 2
[0071] Example 2a): Ginkgo biloba extract with reduced content of biflavones
[0072] 500 g of the extract solution obtained according to the above preparation method was adjusted with water until the ethanol content was about 40% (w / w) and applied to 400 ml (corresponding to 5.7 ml per gram of dry extract) of Sepabeads SP-850 (adsorbent resin) ( Column: about 4×32 cm; flow rate: about 8 ml / min) (step 1)), followed by flushing with a total of about 2 l of 40% ethanol (w / w). 10% (259.3 g) of the resulting solution was concentrated on a rotary evaporator and freeze-dried (step m)): 6.92 g. The remaining 90% of the solution was used in Example 2b).
[0073] It can be seen from the table below that the content of biflavones less than 1 ppm was respectively achieved without substantially changing the content of components related to efficacy.
example 2
[0074] Example 2b): Ginkgo biloba extract with reduced content of 4'-O-methylpyridoxine and biflavones
[0075] 90% (2334.1 g) of the solution obtained in Example 2a) was applied to 25 ml (corresponding to 0.40 ml per gram of dry extract) Amberlite IR-120 (strongly acidic ion exchanger) (column: about 1.5×11 cm; Flow rate: about 10 ml / min) (step 1)), followed by rinsing with 100 ml 40% ethanol (w / w). The resulting solution was concentrated on a rotary evaporator and freeze-dried (step m)): 61.67 g.
[0076] It can be seen from the table below that the 4'-O-methylpyridoxine content of 0.4 ppm and the biflavone content of less than 1 ppm were respectively achieved without substantially changing the content of components related to efficacy.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com